Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

BreathID 13C-Methacetin Breath Test for Detecting Cirrhosis

ClinicalTrials.gov ID: NCT00736840

Public ClinicalTrials.gov record NCT00736840. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 10:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Pivotal Study to Evaluate the Efficacy and Safety of the BreathID® System for Detection of Cirrhosis Using the ¹³C-methacetin Breath Test(MBT)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is a pivotal trial to validate the use of a 13 C labeled substrate called methacetin and the BreathID automatic breath testing system, for determination of cirrhosis in patients with chronic liver disease.

Study identification

NCT ID
NCT00736840
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Meridian Bioscience, Inc.
Industry
Enrollment
414 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2008
Primary completion
Aug 31, 2009
Completion
Aug 31, 2009
Last update posted
Jan 11, 2023

2008 – 2009

United States locations

U.S. sites
8
U.S. states
7
U.S. cities
8
Facility City State ZIP Site status
Cedars Sinai Medical Center Los Angeles California 90048
Henry Ford Health Sytem Detroit Michigan 48202
Cleveland Clinic Cleveland Ohio 44195
University of Pennsylvania Health System Philadelphia Pennsylvania 19104
Medical University of South Carolina Charleston South Carolina 29435
St Luke's Episcopal Hospital, Baylor College of Medicine Houston Texas 77030
Inova Helath System Falls Church Virginia 22042
Virginia Commonwealth University Medical Center Richmond Virginia 23298-0341

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00736840, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 11, 2023 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00736840 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →